HTG Molecular Diagnostics to Present at Canaccord Genuity Growth Conference
TUCSON, Ariz. , Aug. 01, 2018 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced TJ Johnson, Chief Executive Officer of HTG will present at the Canaccord Genuity Growth
- Category:
- Press Releases